12:00 AM
 | 
Oct 25, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Synvisc modified natural hyaluronan regulatory update

BMX said the U.K. National Health Service will reimburse Synvisc as a prescription to...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >